Skip to main content
Premium Trial:

Request an Annual Quote

Fujitsu Computer Systems

Premium

The BioSciences group of Fujitsu Computer Systems said this week that it has officially released the CellInjector Version 2.0 automated microinjection system for large-scale direct injection of agents through cell membranes.

A major new feature of Version 2.0 is the ability to automatically inject adherent cells as well as suspended cells.

For more details on CellInjector Version 2.0, see the May 5 issue of CBA News.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.